United States · FDA National Drug Code directory
Acyclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-928_52cdc887-622c-564c-e063-6294a90ae005
- Product NDC
- 43063-928
- Form
- TABLET
- Composition / generic term
- Acyclovir
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131129
- Source listing expiry
- 20271231
Source-listed ingredients
- ACYCLOVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET in 1 BOTTLE, PLASTIC (43063-928-04) · 43063-928-04
- 5 TABLET in 1 BOTTLE, PLASTIC (43063-928-05) · 43063-928-05
- 15 TABLET in 1 BOTTLE, PLASTIC (43063-928-15) · 43063-928-15
- 25 TABLET in 1 BOTTLE, PLASTIC (43063-928-25) · 43063-928-25
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-928-30) · 43063-928-30
- 40 TABLET in 1 BOTTLE, PLASTIC (43063-928-40) · 43063-928-40
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-928-60) · 43063-928-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →